Market Closed -
Euronext Paris
11:35:26 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
94.6
EUR
|
-1.05%
|
|
-5.02%
|
-7.62%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
602.3
|
762.5
|
989.1
|
1,561
|
1,036
|
1,119
|
1,119
|
-
|
Enterprise Value (EV)
1 |
491.3
|
690.1
|
972.1
|
1,507
|
959.9
|
1,082
|
936.1
|
884.5
|
P/E ratio
|
16.5
x
|
26.6
x
|
51.3
x
|
24.8
x
|
21.6
x
|
20.3
x
|
20.1
x
|
18.6
x
|
Yield
|
0.94%
|
0.75%
|
0.6%
|
0.61%
|
0.91%
|
0.83%
|
0.84%
|
0.88%
|
Capitalization / Revenue
|
1.64
x
|
1.93
x
|
2.31
x
|
2.99
x
|
-
|
2.29
x
|
2.03
x
|
1.94
x
|
EV / Revenue
|
1.34
x
|
1.74
x
|
2.27
x
|
2.89
x
|
-
|
2.04
x
|
1.7
x
|
1.53
x
|
EV / EBITDA
|
8.13
x
|
10.6
x
|
11.6
x
|
12.6
x
|
8.13
x
|
9.57
x
|
8.47
x
|
7.5
x
|
EV / FCF
|
20.8
x
|
18.3
x
|
11.9
x
|
19.9
x
|
20.9
x
|
12.2
x
|
14.1
x
|
12.9
x
|
FCF Yield
|
4.82%
|
5.46%
|
8.42%
|
5.03%
|
4.78%
|
8.23%
|
7.1%
|
7.76%
|
Price to Book
|
1.66
x
|
1.98
x
|
2.67
x
|
3.54
x
|
2.14
x
|
2.11
x
|
1.95
x
|
1.79
x
|
Nbr of stocks (in thousands)
|
11,856
|
11,841
|
11,832
|
11,826
|
11,829
|
11,832
|
11,832
|
-
|
Reference price
2 |
50.80
|
64.40
|
83.60
|
132.0
|
87.60
|
94.60
|
94.60
|
94.60
|
Announcement Date
|
3/20/19
|
3/26/20
|
4/1/21
|
3/24/22
|
3/23/23
|
3/20/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
367.9
|
396
|
427.5
|
521.3
|
-
|
529.3
|
550.9
|
577.3
|
EBITDA
1 |
60.4
|
65.4
|
83.9
|
119.3
|
118
|
113
|
110.5
|
118
|
EBIT
1 |
48.4
|
45.9
|
56.2
|
86.7
|
84.6
|
71.6
|
77.51
|
84.26
|
Operating Margin
|
13.16%
|
11.59%
|
13.15%
|
16.63%
|
-
|
13.53%
|
14.07%
|
14.6%
|
Earnings before Tax (EBT)
1 |
48.58
|
-
|
35.58
|
86.5
|
72.7
|
79
|
77.35
|
85.75
|
Net income
1 |
36.3
|
28.2
|
18.9
|
62.9
|
48
|
55.6
|
55.54
|
60.16
|
Net margin
|
9.87%
|
7.12%
|
4.42%
|
12.07%
|
-
|
10.5%
|
10.08%
|
10.42%
|
EPS
2 |
3.070
|
2.420
|
1.630
|
5.330
|
4.060
|
4.654
|
4.711
|
5.074
|
Free Cash Flow
1 |
23.66
|
37.69
|
81.89
|
75.9
|
45.88
|
89
|
66.46
|
68.68
|
FCF margin
|
6.43%
|
9.52%
|
19.16%
|
14.56%
|
-
|
16.81%
|
12.06%
|
11.9%
|
FCF Conversion (EBITDA)
|
39.18%
|
57.63%
|
97.61%
|
63.62%
|
38.88%
|
78.76%
|
60.14%
|
58.2%
|
FCF Conversion (Net income)
|
65.19%
|
133.66%
|
433.3%
|
120.66%
|
95.59%
|
160.07%
|
119.66%
|
114.16%
|
Dividend per Share
2 |
0.4800
|
0.4800
|
0.5000
|
0.8000
|
0.8000
|
0.8500
|
0.7980
|
0.8340
|
Announcement Date
|
3/20/19
|
3/26/20
|
4/1/21
|
3/24/22
|
3/23/23
|
3/20/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2020 S1
|
2021 Q1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
183.8
|
196.1
|
127.6
|
127.4
|
255
|
132.3
|
133.7
|
136
|
271
|
134
|
135
|
145
|
110.8
|
256.2
|
135.8
|
137
|
146
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
17.9
|
25.3
|
-
|
-
|
50.4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
45.42
|
-
|
-
|
-
|
Operating Margin
|
9.74%
|
12.9%
|
-
|
-
|
19.76%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
17.73%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/25/19
|
7/30/20
|
4/29/21
|
7/29/21
|
7/29/21
|
10/14/21
|
3/24/22
|
7/20/22
|
7/20/22
|
10/13/22
|
3/23/23
|
4/19/23
|
9/7/23
|
9/7/23
|
10/26/23
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
111
|
72.4
|
17
|
53.6
|
76.3
|
130
|
183
|
235
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
23.7
|
37.7
|
81.9
|
75.9
|
45.9
|
89
|
66.5
|
68.7
|
ROE (net income / shareholders' equity)
|
10.4%
|
7.53%
|
7.75%
|
15.5%
|
10.4%
|
10.7%
|
10.2%
|
9.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
8.24%
|
7.2%
|
6.8%
|
6.8%
|
Assets
1 |
-
|
-
|
-
|
-
|
582.3
|
759.2
|
816.8
|
884.7
|
Book Value Per Share
2 |
30.70
|
32.50
|
31.30
|
37.30
|
41.00
|
44.80
|
48.60
|
52.80
|
Cash Flow per Share
2 |
3.200
|
4.400
|
7.800
|
7.580
|
5.310
|
7.420
|
7.730
|
7.920
|
Capex
1 |
14.2
|
14.3
|
10.3
|
13.8
|
17
|
20
|
20.7
|
19
|
Capex / Sales
|
3.86%
|
3.62%
|
2.42%
|
2.65%
|
-
|
3.76%
|
3.76%
|
3.29%
|
Announcement Date
|
3/20/19
|
3/26/20
|
4/1/21
|
3/24/22
|
3/23/23
|
3/20/24
|
-
|
-
|
Last Close Price
94.6
EUR Average target price
105.7
EUR Spread / Average Target +11.70% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.62% | 1.21B | | -9.19% | 6.67B | | +24.75% | 3.7B | | -1.11% | 3.21B | | +6.08% | 1.52B | | -15.13% | 1.37B | | -25.63% | 1.24B | | -10.84% | 1.17B | | -.--% | 1.05B | | -7.07% | 832M |
Veterinary Drugs
|